Case report identifies L-arginine as a potential trigger for central serous retinopathy, suggesting the need for careful drug history evaluations.
Central serous retinopathy (CSR) is a retinal disorder causing serous macular detachment, often linked to stress and corticosteroid use. Drug-induced CSR is rare. We present a case of a 30-year-old male with chronic, recurrent CSR over 2 years, retrospectively linked to L-arginine supplementation for muscle growth, as suggested by a gym trianer. The patient experienced multiple episodes of blurred vision, which did not resolve completely with medication, with optical coherence tomography confirming subretinal fluid. Despite standard treatment, recurrences continued until L-arginine use was identified. Discontinuation led to fluid resolution and visual stabilization. The exact mechanism may involve L-arginine-induced nitric oxide production, causing choroidal vasodilation and hyperpermeability. This case highlights the importance of a thorough drug history in recurrent CSR and raises awareness of L-arginine as a potential trigger. Early identification and withdrawal of the causative agent are crucial for managing chronic CSR.
No takes yet. Share an insight, caveat, or question.
Babu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: